| 10:23a | UBS Adjusts Vertex Pharmaceuticals Price Target to $373 From $342, Maintains Buy Rating | MT |
| 10:14a | UBS Adjusts Regeneron Pharmaceuticals' Price Target to $863 From $862, Maintains Buy Ra.. | MT |
| 09:25a | BIONTECH : Gets a Buy rating from Berenberg | MD |
| 09:16a | Cowen Upgrades Regeneron Pharmaceuticals to Outperform From Market Perform, Adjusts Pri.. | MT |
| 09:14a | South Africa Expects Delivery of Pediatric Pfizer/BioNTech COVID Vaccine Soon | MT |
| 07:59a | Berenberg Bank Adjusts BioNTech SE's Price Target to $300 From $312, Maintains Buy Rati.. | MT |
| 06:33a | Analyst recommendations: Lockheed Martin, Macy's, Nordstrom, Reg.. | |
| 03:28a | Regeneron Pharmaceuticals, Sanofi Says Dupixent Received Expanded Authorization in Euro.. | MT |
| 01:57a | Sanofi, Regeneron Secure First-in-Class Nod for Dupixent to Treat Eosinophilic Esophagi.. | MT |
| 01:08a | Sanofi and Regeneron's Dupixent wins new European Commission approval | RE |
| 01:00a | Regeneron Pharmaceuticals, Inc. and Sanofi Announce European Commission Expands the Mar.. | CI |
| 01/27 | Insider Sell: Vertex Pharmaceuticals | MT |
| 01/27 | Insider Sell: Vertex Pharmaceuticals | MT |
| 01/27 | Pfizer, BioNTech Reportedly in Talks with EU Over Reducing COVID-19 Vaccine Orders | MT |
| 01/27 | EU Mulls Changes to COVID-19 Vaccine Deal With BioNTech, Pfizer | MT |
| 01/27 | Sector Update: Health Care Stocks Flat to Lower Premarket Friday | MT |
| 01/27 | EU Might Buy Fewer Vaccine Doses From Pfizer, BioNTech for Higher Price, Reuters Report.. | DJ |
| 01/27 | Regeneron, Sanofi Say Dupixent Recommended for Expanded Approval in EU to Treat Atopic .. | MT |
| 01/27 | Sanofi, Regeneron Win EU Panel's Backing for Dupixent to Treat Atopic Dermatitis in Chi.. | MT |
| 01/27 | Sanofi's and Regeneron's Dupixent wins new stage of EU regulatory approval | RE |
| 01/27 | Sanofi/Regeneron: Dupixent wins new stage of EU regulatory approval | RE |
| 01/26 | US CDC Continues Inquiry Into Potential Stroke Link from Pfizer, BioNTech Booster Shot | MT |
| 01/26 | FDA advisers back the same COVID vaccine for initial shots, boosters | RE |
| 01/25 | Insider Sell: Vertex Pharmaceuticals | MT |
| 01/24 | Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $286 From $285, Mainta.. | MT |
| 01/24 | Decibel Therapeutics Gets UK Approval for Hearing Loss Clinical Trial in Pediatric Pati.. | MT |
| 01/24 | Morgan Stanley Adjusts Price Target on BeiGene to $325 From $295, Maintains Overweight .. | MT |
| 01/24 | Morgan Stanley Raises Price Target on BioNTech to $216 From $203, Maintains Equal-Weigh.. | MT |
| 01/23 | BioNTech Finishes Construction of First Plasmid DNA Manufacturing Site in Germany | MT |
| 01/20 | Asian Equities Rally in Friday Trading as ADRs Set to Close Week 2% Higher | MT |
| 01/20 | Guggenheim Raises Price Target on BeiGene to $350 From $290, Maintains Buy Rating | MT |
| 01/20 | SVB Securities Adjusts Price Target on BeiGene to $300 From $236, Maintains Outperform .. | MT |
| 01/20 | JPMorgan Upgrades Regeneron Pharmaceuticals to Overweight From Neutral, $850 Price Targ.. | MT |
| 01/20 | Analyst recommendations: AIG Chubb, Netflix, Regeneron... | |
| 01/19 | US FDA Approves BeiGene's Lymphocytic Leukemia Treatment | MT |
| 01/19 | BeiGene's Brukinsa Secures US FDA Approval for Chronic Lymphocytic Leukemia | MT |
| 01/19 | BeiGene Announces BRUKINSA Approved in the U.S. for Chronic Lymphocytic Leukemia | CI |
| 01/19 | Insider Sell: Vertex Pharmaceuticals | MT |
| 01/19 | Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $296 From $293, Maintai.. | MT |
| 01/19 | BeiGene Says Brukinsa Gets UK Marketing Authorization for Chronic Lymphocytic Leukemia,.. | MT |
| 01/19 | Brukinsa (Zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukem.. | CI |
| 01/19 | Four New Indications for BeiGene's Tislelizumab Included in China's Expanded National R.. | MT |
| 01/18 | EU Health Agency Detects No Safety Signals For Pfizer-BioNTech's Updated COVID-19 Shot | MT |
| 01/18 | BeiGene Says China National Reimbursement Drug List Expanded Coverage of its Drugs | MT |
| 01/18 | Pasithea Therapeutics Signs Manufacturing Agreement for Drug Candidate PAS-004 | MT |
| 01/18 | Canaccord Genuity Initiates Coverage on Vertex Pharmaceuticals With Hold Rating, $311 P.. | MT |
| 01/18 | BeiGene Announces Expansion of Coverage on China’s National Reimbursement Drug Lis.. | CI |
| 01/18 | Dermapharm falls back from six-week high | DP |
| 01/18 | Davos 2023: Moderna CEO in talks with China to supply COVID vaccines | RE |
| 01/18 | Analyst recommendations: Adobe, AstraZeneca, Morgan Stanley, Ora.. | |
| 01/17 | Insider Sell: Beigene | MT |
| 01/17 | SVB Securities Upgrades Vertex Pharmaceuticals to Outperform From Market Perform, Adjus.. | MT |
| 01/17 | Trending: Wuxi Biologics Shareholder Plans Block Sale | DJ |
| 01/17 | Wuxi Biologics Drops After Major Shareholder Plans to Sell 1.3% Stake | DJ |
| 01/16 | IG BCE wants drug reserve and 'perspective meeting' with Scholz | DP |
| 01/16 | BIONTECH : Goldman Sachs reiterates its Neutral rating | MD |
| 01/15 | US Health Regulators To Probe Pfizer-BioNTech COVID-19 Shot's Potential Link To Stroke | MT |
| 01/13 | U.S. says Pfizer's bivalent COVID shot may be linked to stroke in older adults | RE |
| 01/13 | RBC Lifts Price Target on Regeneron Pharmaceuticals to $789 From $782, Maintains Sector.. | MT |
| 01/12 | Insider Sell: Beigene | MT |
| 01/11 | BioNTech Asks German Court To Cancel CureVac's mRNA Vaccine Patent | MT |
| 01/11 | Insider Sell: Beigene | MT |
| 01/11 | Vertex Pharmaceuticals Expands Partnership With Arbor to Cover Precision Gene Editing T.. | MT |
| 01/11 | U.S. to announce list of drugs for pricing negotiations Sept. 1 | RE |
| 01/11 | Pharma Stocks Pull European Equities Lower in Wednesday Trading | MT |
| 01/11 | BIONTECH : JP Morgan reaffirms its Neutral rating | MD |
| 01/10 | Insider Sell: Regeneron Pharmaceuticals | MT |
| 01/10 | Transcript : BioNTech SE Presents at 41st Annual J.P. Morgan Healthcare Confe.. | CI |
| 01/10 | Germany's BioNTech buys British AI startup InstaDeep | RE |
| 01/10 | BioNTech to Acquire InstaDeep in Cash-and-Stock Deal | MT |
| 01/10 | BioNTech to Acquire AI Specialist InstaDeep for Up To GBP562 Million | MT |
| 01/10 | BioNTech SE agreed to acquire remaining stake in InstaDeep Ltd for approximately £560 m.. | CI |
| 01/10 | InstaDeep Ltd announced that it expects to receive £562 million in funding from BioNTec.. | CI |
| 01/09 | Transcript : BeiGene, Ltd. Presents at 41st Annual J.P. Morgan Healthcare Con.. | CI |
| 01/09 | Transcript : Regeneron Pharmaceuticals, Inc. Presents at 41st Annual J.P. Mor.. | CI |
| 01/09 | Transcript : Vertex Pharmaceuticals Incorporated Presents at 41st Annual J.P... | CI |
| 01/09 | Regeneron Pharmaceuticals Down Over 8%, on Pace for Largest Percent Decrease Since Marc.. | DJ |
| 01/09 | Tranche Update on Regeneron Pharmaceuticals, Inc.'s Equity Buyback Plan announced on No.. | CI |
| 01/06 | Chinese-made mRNA vaccine starts trial production | RE |
| 01/06 | Pfizer Reportedly Holding Talks With China for Generic COVID-19 Drug Paxlovid | MT |
| 01/06 | 2seventy bio Expands Drug Development Collaboration Project With Regeneron | MT |
| 01/06 | 2seventy Bio, Regeneron in Amended Collaboration | DJ |
| 01/06 | 2seventy bio, Inc. Announces an Amendment to Its Collaboration with Regeneron | CI |
| 01/06 | December Jobs Data Eyed as Exchange-Traded Funds, Equity Futures Muted Premarket Friday | MT |
| 01/06 | BioNTech Teams Up With UK Government to Provide Immunotherapies for Cancer Patients | MT |
| 01/06 | 2seventy bio, Inc. announced that it has received $19.999996 million in funding from Re.. | CI |
| 01/05 | BioNTech, UK Government Sign Deal for mRNA Cancer Immunotherapies, Infectious Disease V.. | MT |
| 01/05 | BioNTech SE Announces Strategic Partnership with UK Government to Provide Up to 10,000 .. | CI |
| 01/05 | Insider Sell: Regeneron Pharmaceuticals | MT |
| 01/05 | BeiGene, Ltd. Announces Center for Drug Evaluation of the China National Medical Produc.. | CI |
| 01/05 | Sensei Biotherapeutics Secures Clinical Supply Deal with Regeneron for Trial | MT |
| 01/05 | China's CanSino: 'positive' interim data on COVID mRNA vaccine booster t.. | RE |
| 01/05 | Sensei Biotherapeutics, Inc. Announces Clinical Supply Agreement with Regeneron | CI |
| 01/04 | Momentum Picks Q1 2023 : 5 stocks for the winter | |
| 01/01 | Valneva's COVID-19 Booster Shot Shows Only Marginally Higher Neutralizing Antibody Resp.. | MT |
| 01/01 | Chinese Regulator Accepts BeiGene's Biologics License Application for Hepatocellular Ca.. | MT |
| 2022 | Vertex Pharmaceuticals Incorporated's Equity Buyback announced on June 24, 2021, has ex.. | CI |
| 2022 | Insider Sell: Regeneron Pharmaceuticals | MT |
| 2022 | Weak Investors Sentiment Weighs on American Depositary Receipts of European Equities | MT |
| 2022 | BeiGene Says Chinese Regulator Accepts Application for Tislelizumab to Treat Liver Canc.. | MT |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
